Table of contents
June 2018 - Volume 77 - Suppl 2
- Speakers Abstracts
- Wednesday, 13 June 2018
- WIN and HOT session
- Little arthritis in PsA and axSpA with newly onset arthritis - does it matter?
- Cancer and inflammation
- Psychological distress and pain; not all in the mind
- Inflammation in the shadow of fibromyalgia
- Shaping the future in systemic sclerosis
- Basic mechanisms of inflammation
- Health Professionals welcome session
- Statistics made simple: a practical approach to complex concepts
- E-health for better care
- EULAR Projects in paediatric rheumatology and UCAN
- Ultrasound basic I
- New drugs - new perspectives: clinical and regulatory issues concerning biosimilars
- Don’t delay, connect today!
- Burning bones
- Delay in treatment and the role of health professionals
- Thursday, 14 June 2018
- Fat and fatty acids: targets for therapy?
- Inclusive school environment for young people with RMDs
- WIN and HOT session
- Can we halt progression of structural damage in axial SpA?
- Reproductive issues in rheumatology
- Clinical challenges in giant cell arteritis in 2018
- Do we still need biopsies to diagnose Sjögren‘s and autoimmune myostitis?
- How monogenetic autoinflammatory diseases help to understand and treat rheumatic diseases
- Joint EULAR - EFIS session: I’ve got a B in my bonnet
- Sustainable healthcare in rheumatology and the role of health professionals
- SSc: From registries to trials - do we have sufficient data and the appropriate design?
- Patient involvement in research: the future of collaborative research. Lessons from the field of rheumatology and beyond
- EULAR Projects in Musculoskeletal Imaging
- MRI
- WIN and HOT session
- To taper or not to taper in RA
- Can we improve the care of gout?
- "Why does BMI matter?"
- Musculoskeletal pain; feeding the opioid epidemic
- What is lupus - syndrome or different entities?
- Genetics, epigenetics and disease: is it all in the genes?
- It’s your move: promoting physical activity in people with RMD’s
- Data visualisation: tables and graphs for publication and presentation I
- Challenges of patient organisations’ in the 21st century
- The EULAR Exercise recommendations for physical activity in people with inflammatory arthritis and osteoarthritis
- Capillaroscopy I
- Ultrasound advanced I
- Immune senescence and ageing
- Friday, 15 June 2018
- Special delivery: intercellular communication
- WIN and HOT session
- Challenges in systemic lupus diagnosis
- Understanding the language of basic research, epidemiology and health services articles
- Joint EULAR - ESSR session on: the role of MR imaging in rheumatic diseases and its clinical implications
- The stromal link to inflammation
- New approaches in measuring what matters to patients
- Innovative treatments for a better quality of life
- EULAR Projects in Investigative Rheumatology
- Laboratory course - from the clinic to the lab and back
- New assessments in clinical practice
- WIN and HOT session
- Advances in biologic therapy of small vessel vasculitis
- Tapering and flaring in PsA and SpA
- Prevention of OA: Yes we can!
- Big data for musculoskeletal research
- From big data to personalised medicine in paediatric rheumatic diseases
- Triple T: T cells, technologies and therapies
- Navigating the world of digital health
- The rheumatologist-orthopaedic surgeon connexion in secondary fracture prevention
- What's new: latest advances in treatment in JIA and osteoarthritis
- Assessment and prevention of RMDs, what have we learned?
- High-end imaging: Looking for the invisible
- Saturday, 16 June 2018
- WIN and HOT Lancet session
- The GI tract in systemic sclerosis - is there light at both ends?
- RA: Is it all in your head?
- Gut bacteria: The boss of the immune system
- Multi-disciplinary management of complex persistent pain
- Osteoarthritis: A vascular disease
- Workshop: Is there a diet for people with RMDs?
- Challenging projects in education and training
- Recommendation session ESSCA
- Fractures: More than bone alone
- Emerging topics in the management of the antiphospholipid syndrome
- The links between gout and kidney function
- Big data in pre-clinical research
- How do you sleep?
- Stratifying connective tissue diseases
- Work and rehabilitation - key priorities for people with RMDs
- The challenges of rheumatology trainees in the clinical learning environment
- HPR highlight session
- Wednesday, 13 June 2018
- Oral presentations
- Wednesday, 13 June 2018
- Cancer and inflammation
- Psychological distress and pain; not all in the mind
- Shaping the future in systemic sclerosis
- Basic mechanisms of inflammation
- Statistics made simple: a practical approach to complex concepts
- E-health for better care
- EULAR Projects in Paediatric Rheumatology and UCAN
- Opening Plenary abstract session
- From NSAIDs to bDMARDs in SpA: what is new?
- RA therapy - new molecules and new strategies
- Doctor, how bad will my rheumatoid become? RA - prognosis, predictors and outcomes
- Immunobiology of vasculitis
- Envisioning new horizons for people with osteoarthritis
- Fracture risk and consequences
- New drugs - new perspectives: clinical and regulatory issues concerning biosimilars
- Movement in musculoskeletal pain; from risk to management
- Don’t Delay, Connect Today!
- Let's improve diagnosis and treatment of orphan diseases
- New driving molecules in systemic sclerosis
- A rollercoaster from bench to bedside and back again: paediatric rheumatology in the 21st century
- Burning bones
- Delay in treatment and the role of health professionals
- Thursday, 14 June 2018
- Fat and fatty acids: targets for therapy?
- Biologics in RA. Improving and maintaining the response
- SLE, Sjögren’s and APS - new criteria, novel diagnostic tools and co-morbidities
- The ‘A-B-C’ of PsA (Assessment, Biologicals, Co-morbidities)
- RA: such a pain, and beyond
- Quickly emerging: science in SSc, myositis and related syndromes
- Can imaging improve diagnosis and outcome in rheumatic diseases
- HPR: Singing power to the people
- Fires and firefighters: switching the immune system on and off
- Inclusive school environment for young people with RMDs
- The building blocks of systemic inflammation
- The crystal maze - etiology and management
- Treatments: friend or foe?
- Can we halt progression of structural damage in axial SpA?
- Reproductive issues in rheumatology
- Do we still need biopsies to diagnose Sjögren‘s and autoimmune myostitis?
- How monogenetic autoinflammatory diseases help to understand and treat rheumatic diseases
- Joint EULAR - EFIS session: I’ve got a B in my bonnet
- Sustainable healthcare in rheumatology and the role of health professionals
- SSc: From registries to trials - do we have sufficient data and the appropriate design?
- Patient involvement in research: the future of collaborative research. Lessons from the field of rheumatology and beyond
- Can we improve the care of gout?
- 'Why does BMI matter?'
- Musculoskeletal pain; feeding the opioid epidemic
- What is lupus - syndrome or different entities?
- Genetics, epigenetics and disease: is it all in the genes?
- It’s your move: promoting physical activity in people with RMD’s
- Challenges of patient organisations’ in the 21st century
- The EULAR Exercise recommendations for physical activity in people with inflammatory arthritis and osteoarthritis
- Immune senescence and ageing
- Friday, 15 June 2018
- Special delivery: intercellular communication
- Biologics in RA. More, more and more about safety
- Clinical and therapeutic aspects of vasculitis
- Axial spondyloarthritis: on the interface between healthy and diseased
- Present and future treatments for SLE, Sjögren's and APS
- From cartilage to bone
- Seeking the pathophysiology of rheumatoid arthritis and spondylarthritis
- HPR: Supporting self-management
- From gene to function
- More money or more education and collaboration?
- The changing therapeutic landscape of PsA
- T/B be or not T/B: adaptive or innate immunity - that is the question
- Pathophysiology and biomarkers in PsA: what impact?
- The art of diagnosis of axial SpA
- Understanding the language of basic research, epidemiology and health
- services articles
- The stromal link to inflammation
- New approaches in measuring what matters to patients
- Innovative treatments for a better quality of life
- Advances in biologic therapy of small vessel vasculitis
- Tapering and flaring in PsA and SpA
- Prevention of OA: Yes we can!
- Big data for musculoskeletal research
- From big data to personalised medicine in paediatric rheumatic diseases
- Triple T: T cells, technologies and therapies
- Navigating the world of digital health
- The rheumatologist-orthopaedic surgeon connexion in secondary fracture prevention
- High-end imaging: looking for the invisible
- Saturday, 16 June 2018
- RA: is it all in your head?
- Battling hyperinflammation in paediatric rheumatic diseases
- Gut bacteria: the boss of the immune system
- Multi-disciplinary management of complex persistent pain
- Osteoarthritis: a vascular disease
- Emerging topics in the management of the antiphospholipid syndrome
- The links between gout and kidney function
- Big data in pre-clinical research
- How do you sleep?
- Stratifying connective tissue diseases
- Work and rehabilitation - key priorities for people with RMDs
- The challenges of rheumatology trainees in the clinical learning environment
- Wednesday, 13 June 2018
- Late breaking abstracts
- Poster Presentations
- Thursday, 14 June 2018
- Guided Poster Tours
- T1: Genetics - from cause to cure
- T2: Adapting the adaptive immune system in health and disease
- T3: Seeking the origins of rheumatoid arthritis
- T4: RA: not just about the joints!
- T5: Anti-TNF: old drugs now but still full of promises
- T6: Spondyloarthritis: causes, questions and consequences
- T7: The impact of treatment on the burden of psoriatic disease
- T8: Cardiovascular co-morbidites in SLE
- T9: SSc, myositis, related syndromes - a bouquet of surprises
- T10: New data on osteoporosis and fracture prevention
- T11: Pain in the joint; managing a widespread problem
- T12: A colourful journey through the landscape of paediatric rheumatology
- T13: Life is not a smooth trip - how pregnancy and life events interfere in rheumatic disease management
- Posters
- Genomics, genetic basis of disease and antigen presentation
- Adaptive immunity (T cells and B cells) in rheumatic diseases
- Rheumatoid arthritis - etiology, pathogenesis and animal models
- Rheumatoid arthritis - prognosis, predictors and outcome
- Rheumatoid arthritis - comorbidity and clinical aspects
- Rheumatoid arthritis - biological DMARDs
- Spondyloarthritis - clinical aspects (other than treatment)
- Psoriatic arthritis
- SLE, Sjögren's and APS - clinical aspects (other than treatment)
- Scleroderma, myositis and related syndromes
- Vasculitis
- Osteoporosis
- Fibromyalgia
- Back pain, mechanical musculoskeletal problems, local soft tissue disorders
- Paediatric rheumatology
- Other orphan diseases
- Public health, health services research and health economics
- Epidemiology, risk factors for disease or disease progression
- Guided Poster Tours
- Friday, 15 June 2018
- Guided Poster Tours
- F1: Digging deep: basic and translational science in paediatric rheumatology
- F2: Let’s discuss RA outcomes
- F3: The hydra beast in RA: a multifaceted disease
- F4: SpA pathophysiology: of mice and men…
- F5: Spondyloarthritis: it looks as if it is only imaging that matters
- F6: Gout epidemiology and therapy
- F7: The enemy in us
- F8: Back to the future: how to mix the old and new treatments for SLE, Sjögren's and APS
- F8: Shaping pathophysiology: new molecules - new views on pathways in SSc, myositis and related syndromes
- F9: Clinical and therapeutic advances in vasculitis
- F10: Novelties in osteoarthritis: clinical aspects
- F11: You can do better studies if you know how
- F12: Searching for outcome measures
- F13: Education for better patients care
- Posters
- Basic science in paediatric rheumatology
- Rheumatoid arthritis - prognosis, predictors and outcome
- Rheumatoid arthritis - comorbidity and clinical aspects
- Rheumatoid arthritis - biological DMARDs
- Spondyloarthritis - etiology, pathogenesis and animal models
- Spondyloarthritis - clinical aspects (other than treatment)
- Crystal diseases, metabolic bone diseases and bone diseases other than osteoporosis
- SLE, Sjögren’s and APS - etiology, pathogenesis and animal models
- SLE, Sjögren's and APS - treatment
- SLE, Sjögren's and APS - clinical aspects (other than treatment)
- Systemic sclerosis, myositis and related syndromes - etiology, pathogenesis and animal models
- Scleroderma, myositis and related syndromes
- Vasculitis
- Osteoarthritis
- Diagnostics and imaging procedures
- Public health, health services research and health economics
- Validation of outcome measures and biomarkers
- Rehabilitation
- Education
- Guided Poster Tours
- Saturday, 16 June 2018
- Guided Poster Tours
- S1: Born to be wild
- S2: The good, the bad and the ugly: soluble mediators in inflammation
- S3: The joint connection: cartilage, bone and synovial tissue
- S4: Predicting tomorrow today: prognosis, predictors and outcomes of RA
- S5: Breakout news on non-TNF biologics in RA
- S6: Novel insights on non-biologics in RA
- S7: Treatment in SpA: does it matter?
- S8: PsA: a whole range of (subclinical) (co)morbidities!
- S9: Beware the bug!
- S10: SLE, Sjögren’s and APS - novel predictors of disease activity and long-term outcomes
- S11: SSc, myositis, related syndromes - novel ideas take place
- S12: Be familiar with orphan diseases
- S13: Imaging strategies in the management of arthritis
- S14: This poster tour might be risky!
- Posters
- Innate immunity in rheumatic diseases
- Cytokines and inflammatory mediators
- Cartilage, synovium and bone
- Rheumatoid arthritis - prognosis, predictors and outcome
- Rheumatoid arthritis - comorbidity and clinical aspects
- Rheumatoid arthritis - biological DMARDs
- Rheumatoid arthritis - non biologic treatment and small molecules
- Spondyloarthritis - treatment
- Psoriatic arthritis
- Crystal diseases, metabolic bone diseases and bone diseases other than osteoporosis
- Infection-related rheumatic diseases
- SLE, Sjögren's and APS - clinical aspects (other than treatment)
- Scleroderma, myositis and related syndromes
- Vasculitis
- Osteoarthritis
- Other orphan diseases
- Diagnostics and imaging procedures
- Epidemiology, risk factors for disease or disease progression
- Guided Poster Tours
- Thursday, 14 June 2018
- Abstracts Accepted for Publication
- Genomics, genetic basis of disease and antigen presentation
- Adaptive immunity (T cells and B cells) in rheumatic diseases
- Innate immunity in rheumatic diseases
- Cytokines and inflammatory mediators
- Cartilage, synovium and bone
- Rheumatoid arthritis - etiology, pathogenesis and animal models
- Spondyloarthritis - etiology, pathogenesis and animal models
- SLE, Sjögren's and APS - etiology, pathogenesis and animal models
- Systemic sclerosis, myositis and related syndromes - etiology, pathogenesis and animal models
- Rheumatoid arthritis - prognosis, predictors and outcome
- Rheumatoid arthritis - comorbidity and clinical aspects
- Rheumatoid arthritis - biological DMARDs
- Rheumatoid arthritis - non biologic treatment and small molecules
- SLE, Sjögren's and APS - treatment
- SLE, Sjögren's and APS - clinical aspects (other than treatment)
- Vasculitis
- Scleroderma, myositis and related syndromes
- Spondyloarthritis - treatment
- Spondyloarthritis - clinical aspects (other than treatment)
- Psoriatic arthritis
- Osteoarthritis
- Osteoporosis
- Crystal diseases, metabolic bone diseases and bone diseases other than osteoporosis
- Infection-related rheumatic diseases
- Fibromyalgia
- Back pain, mechanical musculoskeletal problems, local soft tissue disorders
- Paediatric rheumatology
- Other orphan diseases
- Diagnostics and imaging procedures
- Public health, health services research and health economics
- Epidemiology, risk factors for disease or disease progression
- Validation of outcome measures and biomarkers
- Education
- Health Professionals in Rheumatology Abstracts
- Oral presentations
- Poster Presentations
- Thursday, 14 June 2018
- Guided Poster Tours
- Posters
- HPR Patients’ perspectives, functioning and health (descriptive: qualitative or quantitative)
- HPR Measuring health (development and measurement properties of PROs, tests, devices)
- HPR Epidemiology and public health (including prevention)
- HPR Interventions (educational, physical, social and psychological)
- HPR Professional education, training and competencies
- HPR Interventions (educational, physical, social and psychological)
- HPR Patients’ perspectives, functioning and health (descriptive: qualitative or quantitative)
- HPR Interventions (educational, physical, social and psychological)
- Friday, 15 June
- Guided Poster Tours
- Posters
- HPR Patients’ perspectives, functioning and health (descriptive: qualitative or quantitative)
- HPR Service developments, innovation and economics in healthcare
- HPR Professional education, training and competencies
- HPR Patients’ perspectives, functioning and health (descriptive: qualitative or quantitative)
- HPR Epidemiology and public health (including prevention)
- HPR Interventions (educational, physical, social and psychological)
- HPR Patients’ perspectives, functioning and health (descriptive: qualitative or quantitative)
- HPR Service developments, innovation and economics in healthcare
- HPR Patients’ perspectives, functioning and health (descriptive: qualitative or quantitative)
- Saturday, 16 June 2018
- Thursday, 14 June 2018
- Abstracts Accepted for Publication
- HPR Measuring health (development and measurement properties of PROs, tests, devices)
- HPR Epidemiology and public health (including prevention)
- HPR Interventions (educational, physical, social and psychological)
- HPR Patients’ perspectives, functioning and health (descriptive: qualitative or quantitative)
- HPR Service developments, innovation and economics in healthcare
- HPR Professional education, training and competencies
- People with Arthritis and Rheumatism in Europe Abstracts
- Oral presentations
- Poster Presentations
- Guided Poster Tours
- Thursday, 14 June 2018
- Friday, 15 June 2018
- Thursday, 14 June 2018 to Saturday, 16 June 2018
- Posters
- Best practice campaigning
- Innovations in arthritis health care
- Patient information and education
- Best practice campaigning
- Patient information and education
- Building patient led organisations
- Work and rehabilitation
- Patient information and education
- Best practice campaigning
- Patient information and education
- Work and rehabilitation
- Arthritis research
- Patient information and education
- Posters
- Abstracts Accepted for Publication
- Guided Poster Tours